From the Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin 53705.
From the Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin 53705,; Pathology and Laboratory Medicine Service, William S. Middleton Memorial Veterans Hospital, Department of Veterans Affairs Medical Center, Madison, Wisconsin 53705, and; UW Carbone Cancer Center, Madison, Wisconsin 53792.
J Biol Chem. 2013 Jul 19;288(29):21184-21196. doi: 10.1074/jbc.M113.481119. Epub 2013 Jun 2.
We have shown previously that the murine prolactin/growth hormone family member proliferin plays a pivotal role in angiogenesis induced by the FGF2/STAT5 signaling cascade. To delineate the signaling pathway downstream of STAT5 in the human system, where proliferin does not exist, we expressed constitutively active (CA) or dominant-negative (DN) mutant STAT5A in hCMEC/D3 human brain endothelial cells. We found that conditioned medium from CA-STAT5A- but not from DN-STAT5A-overexpressing endothelial cells (EC) is sufficient to induce EC migration and tube formation but not proliferation, indicating that STAT5A regulates the secretion of autocrine proangiogenic factors. We identified prolactin (PRL) as a candidate autocrine factor. CA-STAT5A expression stimulates PRL production at the RNA and protein level, and STAT5A binds to the PRL promoter region, suggesting direct transcriptional regulation. Medium conditioned by CA-STAT5A-overexpressing EC induces phosphorylation of the PRL receptor and activates MAPK. Knockdown of PRL expression by shRNA or blocking of PRL activity with neutralizing antibodies removed the CA-STAT5A-dependent proangiogenic activity from the conditioned medium of EC. The addition of recombinant PRL restores this activity. STAT5A-induced PRL in the conditioned medium can activate STAT5, STAT1, and to a lesser extent STAT3 in hCMEC/D3 cells, suggesting the existence of a positive feedback loop between STAT5 and PRL that promotes angiogenesis. Furthermore, we find that VEGF, a potent proangiogenic factor, is induced by activation of STAT5A, and VEGF induction depends on PRL expression. These observations demonstrate a STAT5/PRL/VEGF signaling cascade in human brain EC and implicate PRL and VEGF as autocrine regulators of EC migration, invasion, and tube formation.
我们之前已经证明,鼠类催乳素/生长激素家族成员增殖素在 FGF2/STAT5 信号级联诱导的血管生成中起着关键作用。为了描绘人类系统中增殖素不存在时 STAT5 的下游信号通路,我们在 hCMEC/D3 人脑内皮细胞中表达组成型激活(CA)或显性负(DN)突变 STAT5A。我们发现,CA-STAT5A 表达而非 DN-STAT5A 过表达内皮细胞(EC)的条件培养基足以诱导 EC 迁移和管状形成,但不能诱导增殖,表明 STAT5A 调节自分泌促血管生成因子的分泌。我们鉴定出催乳素(PRL)作为候选自分泌因子。CA-STAT5A 表达刺激 PRL 在 RNA 和蛋白质水平的产生,并且 STAT5A 结合到 PRL 启动子区域,表明直接转录调节。CA-STAT5A 过表达 EC 条件培养基诱导 PRL 受体的磷酸化并激活 MAPK。通过 shRNA 敲低 PRL 表达或用中和抗体阻断 PRL 活性可从 EC 的条件培养基中去除 CA-STAT5A 依赖性促血管生成活性。添加重组 PRL 可恢复此活性。STAT5A 在条件培养基中诱导的 PRL 可激活 hCMEC/D3 细胞中的 STAT5、STAT1,并在较小程度上激活 STAT3,表明 STAT5 和 PRL 之间存在促进血管生成的正反馈环。此外,我们发现 VEGF,一种有效的促血管生成因子,被 STAT5A 的激活诱导,并且 VEGF 的诱导取决于 PRL 的表达。这些观察结果表明在人脑 EC 中存在 STAT5/PRL/VEGF 信号级联,并且表明 PRL 和 VEGF 是 EC 迁移、侵袭和管状形成的自分泌调节剂。